VWR International

The distribution agreement covers Zymo's nucleic acid products, including ones for DNA purification, RNA extraction, and microbiomic analysis.

VWR will act as the exclusive distributor for Biocept's liquid biopsy blood collection tubes everywhere in the world except China.

The kits are based on the company's ICE-COLD PCR technology and enable the detection of genetic mutations in any type of sample.

The deal covers SGI-DNA's line of DNA construct assembly kits, which are based on its Gibson Assembly DNA cloning approach, in North America and Europe.

VWR will distribute a broader lineup of NEB's products, which will be made available through e-business and other sales channels.

NEW YORK (GenomeWeb News) – Illumina said today that VWR International will distribute its portfolio of qPCR products in the US.
Illumina's qPCR portfolio includes the Eco Real-Time PCR System and NuPCR reagents.

Amresco manufactures and supplies biochemicals and reagents for use in research in the molecular biology, life sciences, proteomics, clinical, and histology markets.

The agreement gives VWR the rights to distribute Kapa's portfolio of products for applications such as high-fidelity PCR, fast PCR, long-range PCR, whole-blood PCR, crude-sample PCR, and single-protocol PCR.

The agreement covers Kapa’s reagents for DNA amplification, sequencing, and molecular diagnostic applications.

The companies plan to offer joint services for a range of lab needs, from pipettes to LC/MS systems.

Pages

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.